
Alkem Labs Q3 Results: Profit and margin expand from last year; dividend announced
Alkem Labs Q3 Results: For the first nine months of FY25, EBITDA margin stood at 21.6% as against FY25 guidance of 18.5-19%.

Alkem Labs Q3 Results: For the first nine months of FY25, EBITDA margin stood at 21.6% as against FY25 guidance of 18.5-19%.

The company said that the total price increase in Q3 was 2%, with a further 4-4.5% hike expected by FY25-end.

Wockhardt’s EBITDA surged multifold to ₹128 crore, reflecting a 246% jump from ₹37 crore in Q3 FY24.

The draft regulations released last year suggested that 5% of the provisions should be made on all existing and fresh project loans which are in…

The latest order from the market regulator is part of a series of steps aimed at curbing the influence of unregistered advisors wooing small investors…

Gaekwad has proposed an open offer to acquire a 55% stake in Religare at ₹275 per share, significantly higher than the Burman family’s offer pegged…

Shares of Ola Electric are now trading below their IPO price and have more than halved from their post-listing high of ₹157.

Stefanie Holtze-Jen, Chief Investment Officer at Deutsche Bank AG, expects gold to reach $3,000 per ounce soon.

The auto business is expected to report volume growth of 16% and tractors segment may rise 20% year-on-year. Mix broadly similar for tractors at 33%…

Although shares of Bikaji Foods have corrected 36% from their post-listing high, the stock still trades at a premium of over 100% to their IPO…